Market Overview:
The global womens health diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of various diseases among women, rising awareness about womens health diagnostics, and technological advancements in the field of womens health diagnostics. The prenatal testing segment is expected to account for the largest share of the global womens health diagnostics market in 2018. This segment is expected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to increasing demand for prenatal tests due to rising incidence rates of genetic disorders and chromosomal abnormalities among women worldwide.
Product Definition:
Womens Health Diagnostics is the branch of medicine that specializes in diagnosing and treating diseases or disorders that affect womens health. The field of womens health diagnostics is important because it helps to identify and treat conditions that can impact a woman's quality of life.
Prenatal Testing:
Prenatal testing is a procedure to check the fetus for various genetic and congenital abnormalities. Prenatal testing market is expected to witness lucrative growth over the forecast period owing to factors such as growing awareness about pre-natal diagnosis, increasing population of pregnant women, rising demand for early detection of congenital diseases in infants and fetus, technological advancements in prenatal diagnostics tests.
Down Syndrome:
Down syndrome is a chromosomal disorder caused by an extra chromosome. It is the most common trisomy in humans and the most frequently occurring cause of congenital heart disease, Down’s syndrome. According to data published by National Institute of Health (NIH), one in every 691 babies born in the U.S will have down syndrome.
Application Insights:
The market is segmented into hospitals and home care based on application. Hospitals held the largest share in 2017 owing to the presence of a large number of women¢â‚¬â„¢s health diagnostic laboratories in hospitals. The availability of advanced diagnostics equipment and experienced lab technicians at these facilities boosts the overall revenue generated by this segment.
On the other hand, home care is expected to witness lucrative growth over the forecast period due to increasing awareness about womens health issues coupled with rising incidences of infertility among couple, growing adoption rate for self-testing kits, and high demand for sensitive & rapid tests that are applicable even at home without any laboratory infrastructure or personnel. This factor has led to an increase in demand for such types of tests over past few years across various regions worldwide including North America, Europe, Asia Pacific etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for advanced maternal care products and increasing awareness about women health issues. The region is expected to maintain its position during the forecast period owing to continuous innovations in maternal care products and rising demand for cost-effective diagnostic solutions.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure, growing population base with higher risk of congenital disorders, increase in disposable income & consumer awareness about early diagnosis leading towards better outcomes at lower costs. Moreover, an increase in foreign investments coupled with favorable government policies are some other factors that are likely contribute towards regional growth during the forecast period (2018 - 2030).
Growth Factors:
- Increasing incidence of lifestyle diseases in women
- Growing awareness about womens health and preventive care
- Rising demand for early diagnosis and treatment of diseases
- Technological advancements in diagnostic imaging and laboratory testing procedures
- Proliferation of private healthcare sector and increasing investments by healthcare players
Scope Of The Report
Report Attributes
Report Details
Report Title
Womens Health Diagnostics Market Research Report
By Type
Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Other
By Application
Hospitals, Home Care
By Companies
Agilent Technologies, Inc., Ariosa Diagnostics, Inc, Bio-Rad Laboratories, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Natera, Inc, PerkinElmer, Inc, Sequenom, Inc, LifeCodexx, Cenata, Berrygenomics, BGI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Womens Health Diagnostics Market Report Segments:
The global Womens Health Diagnostics market is segmented on the basis of:
Types
Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies, Inc.
- Ariosa Diagnostics, Inc
- Bio-Rad Laboratories, Inc
- Illumina, Inc
- Laboratory Corporation of America Holdings
- Natera, Inc
- PerkinElmer, Inc
- Sequenom, Inc
- LifeCodexx
- Cenata
- Berrygenomics
- BGI
Highlights of The Womens Health Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prenatal Testing
- Down Syndrome
- HPV
- Fertility Test
- Pregnancy Test
- Other
- By Application:
- Hospitals
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Womens Health Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Womens Health Diagnostics is a company that provides women's health services and products. The company offers a variety of services, including screenings for breast cancer, cervical cancer, and other reproductive health issues; tests for sexually transmitted infections; and consultations on contraception.
Some of the major players in the womens health diagnostics market are Agilent Technologies, Inc., Ariosa Diagnostics, Inc, Bio-Rad Laboratories, Inc, Illumina, Inc, Laboratory Corporation of America Holdings, Natera, Inc, PerkinElmer, Inc, Sequenom, Inc, LifeCodexx, Cenata, Berrygenomics, BGI.
The womens health diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Womens Health Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Womens Health Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Womens Health Diagnostics Market - Supply Chain
4.5. Global Womens Health Diagnostics Market Forecast
4.5.1. Womens Health Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Womens Health Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Womens Health Diagnostics Market Absolute $ Opportunity
5. Global Womens Health Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Womens Health Diagnostics Market Size and Volume Forecast by Type
5.3.1. Prenatal Testing
5.3.2. Down Syndrome
5.3.3. HPV
5.3.4. Fertility Test
5.3.5. Pregnancy Test
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Womens Health Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Womens Health Diagnostics Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Home Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Womens Health Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Womens Health Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Womens Health Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Womens Health Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Womens Health Diagnostics Demand Share Forecast, 2019-2026
9. North America Womens Health Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Womens Health Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Womens Health Diagnostics Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Home Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Womens Health Diagnostics Market Size and Volume Forecast by Type
9.7.1. Prenatal Testing
9.7.2. Down Syndrome
9.7.3. HPV
9.7.4. Fertility Test
9.7.5. Pregnancy Test
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Womens Health Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Womens Health Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Womens Health Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Womens Health Diagnostics Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Home Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Womens Health Diagnostics Market Size and Volume Forecast by Type
10.7.1. Prenatal Testing
10.7.2. Down Syndrome
10.7.3. HPV
10.7.4. Fertility Test
10.7.5. Pregnancy Test
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Womens Health Diagnostics Demand Share Forecast, 2019-2026
11. Europe Womens Health Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Womens Health Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Womens Health Diagnostics Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Home Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Womens Health Diagnostics Market Size and Volume Forecast by Type
11.7.1. Prenatal Testing
11.7.2. Down Syndrome
11.7.3. HPV
11.7.4. Fertility Test
11.7.5. Pregnancy Test
11.7.6. Other
11.8. Basis Point Share (BPS Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Womens Health Diagnostics Demand Share, 2019-2026
12. Asia Pacific Womens Health Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Womens Health Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Womens Health Diagnostics Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Home Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Womens Health Diagnostics Market Size and Volume Forecast by Type
12.7.1. Prenatal Testing
12.7.2. Down Syndrome
12.7.3. HPV
12.7.4. Fertility Test
12.7.5. Pregnancy Test
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Womens Health Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Womens Health Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Womens Health Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Womens Health Diagnostics Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Home Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Womens Health Diagnostics Market Size and Volume Forecast by Type
13.7.1. Prenatal Testing
13.7.2. Down Syndrome
13.7.3. HPV
13.7.4. Fertility Test
13.7.5. Pregnancy Test
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Womens Health Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Womens Health Diagnostics Market: Market Share Analysis
14.2. Womens Health Diagnostics Distributors and Customers
14.3. Womens Health Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ariosa Diagnostics, Inc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad Laboratories, Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Illumina, Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Laboratory Corporation of America Holdings
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Natera, Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PerkinElmer, Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sequenom, Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LifeCodexx
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cenata
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Berrygenomics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BGI
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook